Pharmaceutical brand teams spend millions monitoring what doctors, patients, and payers say about their drugs. Most of that investment goes
What AI Knows About Your Drug vs. Your Competitors Read Post »
Every pharmaceutical company files patents to protect its investment. Every one of those patents is a public document. And yet,
Read the Patent, Beat the Competition: The Intelligence Gap Most Pharma Teams Leave Open Read Post »
The Fork in the Road That Determines Billions When a drug company files for FDA approval of a new medicine,
A complete operational guide to locating abandoned and lapsed pharmaceutical patents for generic market entry The Money Is in the
Find Expired Drug Patents Before Your Competitors Do Read Post »
The Moment Everyone Prepares for and Nobody Fully Survives The day a blockbuster drug’s core patent expires is circled on
How chatbots became the most influential prescribing influencers in pharma, what happens when they get it wrong, and the monitoring
AI Is Your Drug’s New KOL — and You’re Not Tracking It Read Post »
The math is brutal and straightforward. A branded drug generating $800 million annually can lose 80 to 90 percent of
The Calendar Is Your Competitive Weapon Every pharmaceutical company has a patent expiry problem. Not because patents expire — that
The Hierarchy Problem in Pharmaceutical IP Every pharmaceutical patent portfolio has a hierarchy, whether the company managing it acknowledges one
Sign in or create a free account to read this DrugPatentWatch article
